Immix Biopharma, Inc. (IMMX)
9.22
+0.22
(+2.44%)
USD |
NASDAQ |
Jun 01, 16:00
9.22
0.00 (0.00%)
After-Hours: 20:00
Immix Biopharma EPS Diluted (Quarterly) : -0.1822 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1646 |
| Relay Therapeutics, Inc. | -0.4075 |
| Annexon, Inc. | -0.2273 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.09M |
| Total Expenses (Quarterly) | 10.09M |
| Enterprise Value | 400.16M |
| Earnings Yield | -9.98% |
| Normalized Earnings Yield | -9.976 |